|
Volumn 30, Issue 2, 2003, Pages 231-235
|
Histoculture drug response assay (HDRA) guided induction concurrent chemoradiotherapy for mediastinal node-positive non-small cell lung cancer
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOCETAXEL;
DRUG DERIVATIVE;
ETOPOSIDE;
PACLITAXEL;
TAXOID;
VP P PROTOCOL;
VP-P PROTOCOL;
AGED;
ARTICLE;
CELL CULTURE;
DRUG SCREENING;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG RESECTION;
LUNG TUMOR;
LYMPH NODE METASTASIS;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG SCREENING ASSAYS, ANTITUMOR;
ETOPOSIDE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PNEUMONECTOMY;
TAXOIDS;
TUMOR CELLS, CULTURED;
|
EID: 0037318143
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|